Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Narrowing in on why endometriosis can lead to cancer

Narrowing in on why endometriosis can lead to cancer

News Releases Mar 3, 2018 3 minutes

Discovery debunks previously held notions about gene mutations and cancer.

It is a condition that affects one in 10 girls and women during their reproductive years, and VCH Research Institute researcher Dr. Michael Anglesio and colleagues have uncovered new clues about how it affects cells in the body.

Endometriosis is the development of uterine-lining tissues outside the uterus. It is often associated with pelvic pain, heavier periods and sometimes infertility. It is a benign condition and exceptionally common, but can also be a precursor to the development of cancer in rare cases.

“Around one million Canadian girls and women have endometriosis, but only 0.5 per cent will develop ovarian cancer.”

Anglesio has been interested in studying endometriosis lesions that lead to cancer since joining the OVCARE team in 2010. He wanted to know why endometriosis sometimes does not turn into cancer. 

Michael Anglesio and Vancouver-based study co-authors take a time-out from their research for a group curling session.
(Back L-R) Niki Boyd, Basile Tessier-Cloutier, Amy Lum, Julie Ho, Natasha Orr, Vivian Lac. (Front L-R) Paul Yong, Michael Anglesio, David Huntsman, Janine Senz.
Photo by Dr. Tony Karnezi

When a colleague, Dr. Paul Yong, approached him with several endometriosis specimens and a similar interest in uncovering what was going on in non-cancerous endometriosis cells, Anglesio jumped at the opportunity. “We wondered if non-cancerous endometriosis samples had similar mutations to those in cancer cases where endometriosis was present,” says Anglesio. 

“We discovered that the same kinds of mutations were present in both cancerous and non-cancerous cases.”

This discovery runs counter to the prior belief that certain mutations in endometriosis cells would lead to cancer. In other words, Anglesio notes, “it was believed that any mutations in endometriosis were driving malignant transformation.” In the long-term, this research could also shed light on whether some gene mutations in endometriosis are indeed precursors to ovarian-related cancer.

Research shows that endometriosis cells can behave like cancerous ones

For their paper, “Cancer-associated mutations in endometriosis without cancer,” Anglesio and colleagues analyzed DNA in endometriosis tissue samples and the findings from two independent research teams.

The teams analyzed 39 deep infiltrating endometriosis lesions—a type of endometriosis lesion that invades an organ more than five millimetres below the surface of the tissue. They found that the exact same mutation in cells was being propagated to other parts of the body in the form of new endometriosis lesions. This told the researchers that the endometriosis was somehow able to move, a characteristic normally only seen in cancer and known as metastasis.

“It was surprising to see this metastasis in a non-malignant disease.” says Anglesio.

Despite this, the mutated endometriosis cells were not strongly correlated with cancer. Cancer-driving mutations were discovered in 10 of the 39 non-malignant lesions—far more cases than would be expected if the mutations resulted in the endometriosis becoming cancerous. This points to the fact that mutations can be present in both cancerous and non-cancerous endometriosis.

“We have only recently made this discovery, and now we know that we have to develop new ways to screen for endometriosis that could potentially become malignant,” says Anglesio.

Despite being smaller than a pin head, small nests of endometriosis like these can cause big problems for patients.

“This is the first step to developing screening for endometriosis or endometriosis-associated ovarian cancers. We know that we need to look at indicators other than just gene mutations. As such, we are working with surgeons to find ways to access tissue samples and create a new classification system for endometriosis.” 

 

Researchers

Michael Anglesio

Related Articles

Enhancing ovarian cancer diagnostics using AI technology

B.C.-developed strategy reduces ovarian cancer risk: new study

Supporting women’s cancer journeys one listener at a time

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Ovarian Cancer Research Centre

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Investigator Awards 2023 Recipients

Mar 21, 2023 award
Type
Stories

Ask an expert: Is my menstrual pain normal, or could I have endometriosis?

Mar 16, 2023 women, endometriosis, preventative
Type
Stories

Honing in on precision treatments for endometriosis

Mar 14, 2023 genetics, treatment options
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy